Original Article| Volume 23, ISSUE 6, P1275-1281, July 2014

HindIII Polymorphism in the Lipoprotein Lipase Gene and Hypertensive Intracerebral Hemorrhage in the Chinese Han Population


      To investigate the relationship between the HindIII polymorphism and hypertensive intracerebral hemorrhage (HIH) and lipid metabolism.


      A polymerase chain reaction–restriction fragment length polymorphism assay and the chain termination DNA sequencing method were used to determine the HindIII genotypes of 267 subjects, which included 120 cerebral hemorrhagic patients and 147 controls. The fasting levels of lipids and glucose in the plasma were used to measure the effect of genotype on HIH risk factors.


      The frequency of the T allele of the HindIII polymorphism in the HIH group was 90.8%. The frequency of the G allele was 9.2%. In the control group, the frequencies were 82.3% T and 17.7% G, which indicated that the proportion of the G allele in the HIH patient group was significantly lower than in the control group (P < .05). The frequency of GG + GT genotypes in HIH patients (P < .05) and the plasma triglyceride (TG) levels in these patients (P < .05) were also lower than in the control group. The levels of plasma TG, low-density lipoprotein cholesterol, glucose, systolic blood pressure, and diastolic blood pressure in the HIH group were higher than in the controls (P < .05). After controlling for risk factors related to HIH, the HindIII G allele was negatively correlated with the incidence of HIH (odds ratio = .417, 95% confidence interval: .193-.901).


      The HindIII G allele may be a protective factor against the development of HIH among the Han Chinese population.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Murthy V.
        • Julien P.
        • Gagne C.
        Molecular pathobiology of the human lipoprotein lipase gene.
        Pharmacol Ther. 1996; 70: 101-135
        • Lalouel J.-M.
        • Wilson D.E.
        • Iverius P.-H.
        Lipoprotein lipase and hepatic triglyceride lipase: molecular and genetic aspects.
        Curr Opin Lipidol. 1992; 3: 86-96
        • Jemaa R.
        • Fumeron F.
        • Poirier O.
        • et al.
        Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study.
        J Lipid Res. 1995; 36: 2141-2146
        • Yang W.
        • Huang J.
        • Ge D.
        • et al.
        Lipoprotein lipase gene is in linkage with blood pressure phenotypes in Chinese pedigrees.
        Hum Genet. 2004; 115: 8-12
        • Goodarzi M.O.
        • Guo X.
        • Taylor K.D.
        • et al.
        Lipoprotein lipase is a gene for insulin resistance in Mexican Americans.
        Diabetes. 2004; 53: 214-220
        • Xie C.
        • Wang Z.C.
        • Liu X.F.
        • et al.
        The common biological basis for common complex disease: evidence from lipoprotein lipase gene.
        Eur J Hum Genet. 2010; 18: 3-7
        • Fisher R.M.
        • Humphries S.E.
        • Talmud P.J.
        Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis.
        Atherosclerosis. 1997; 135: 145-159
        • Crameri A.
        • Biondi E.
        • Kuehnle K.
        • et al.
        The role of seladin-1/DHCR24 in cholesterol biosynthesis. APP processing and Abeta generation in vivo.
        EMBO J. 2006; 25: 432-443
        • Lendon C.L.
        • Talbot C.J.
        • Craddock N.J.
        • et al.
        Genetic association studies between dementia of the Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population.
        Neurosci Lett. 1997; 222: 187-190
        • Bales K.R.
        • Dodart J.C.
        • Demattos R.B.
        • et al.
        Apolipoprotein E, amyloid and Alzheimer disease.
        Mol Interv. 2002; 2 (339): 363-375
        • Chen Q.
        • Razzaghi H.
        • Demirci F.Y.
        • et al.
        Functional significance of lipoprotein lipase HindⅢ polymorphism associated with the risk of coronary artery disease.
        Atherosclersis. 2008; 200: 102-108
        • Morabia A.
        • Cayanis E.
        • Costanza M.C.
        • et al.
        Association between lipoprotein lipase (LPL) gene and blood lipids: a common variant for a common trait?.
        Genet Epidemiol. 2003; 24: 309-321
        • Tu X.
        • Tu J.
        • Wen X.
        • et al.
        A study of lipoprotein lipase gene intron 8 polymorphism in Chinese Han race essential hypertension patients.
        Int J Cardiol. 2005; 99: 263-267
        • Munshi A.
        • Badu M.S.
        • Kaul S.
        • et al.
        Association of LPL gene variant and LDL, HDL, VLDL cholesterol and triglyceride levels with ischemic stroke and its subtypes.
        J NeurolSei. 2012; 318: 51-54
        • Amer A.K.
        • Moustapha M.S.Z.
        • EL-Sobky M.S.
        • et al.
        HindⅢ polymorphism of lipoprotein lipase gene and its contribution to coronary artery disease in Egyptian.
        Aust J Basic Appl Sci. 2010; 4: 6641-6646
        • Xian-quan A.
        • Li-shen R.
        • Ke W.
        • et al.
        Study HindⅢ restriction enzyme cutting site of lipoprotein lipase gene polymorphism in Chinese Korea and Chinese Han people in Jilin province.
        Chin J Lab Diagn. 2010; 10: 1582-1584
        • Xu E.
        • Li W.
        • Zhan L.
        • et al.
        Polymorphisms of the lipoprotein lipase gene are associated with atherosclerotic cerebral infarction in the Chinese.
        Neuroscience. 2008; 155: 403-408
        • Psaty B.M.
        • Anderson M.
        • Kronmal R.A.
        • et al.
        The association between lipid levels and the risks of incident myocardial infarction, stroke, and total mortality: the Cardiovascular Health Study.
        J Am Geriatr Soc. 2004; 52: 1639-1647
        • Sturgeon J.D.
        • Folsom A.R.
        • Longstreth Jr., W.T.
        • et al.
        Risk factors for intracerebral hemorrhage in a pooled prospective study.
        Stroke. 2007; 38: 2718-2725
        • Gomis Cortina M.
        • Rodríguez Campello A.
        • Jiménez Conde J.
        • et al.
        Monocyte count is an underlying marker of lacunar subtype of hypertensive small vessel disease.
        Eur J Neurol. 2008; 15: 671-676
        • Patel A.
        • Woodward M.
        • Campbell D.J.
        • et al.
        Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease.
        Eur Heart J. 2005; 26: 1910-1915
        • Nakaya N.
        • Kita T.
        • Mabuchi H.
        • et al.
        Large-scale cohort study on the relationship between serum lipid concentrations and risk of cerebrovascular disease under low-density simvastatin in Japanese Lipid Intervention Trial (J-LIT).
        Cric J. 2005; 69: 1016-1021
        • Zia E.
        • Pessah-Rasmussen H.
        • Khan F.A.
        • et al.
        Risk factors for primary intracerebral hemorrhage: a population-based nested case-control study.
        Cerebrovasc Dis. 2006; 21: 18-25
        • Zhou J.F.
        • Wang J.Y.
        • Luo Y.E.
        • et al.
        Influence of hypertension, lipometabolism disorders, obesity and other lifestyle on spontaneous intracerebral hemorrhage.
        Biomed Environ Sci. 2003; 16: 295-303
        • Sato A.
        • Asakura Y.
        • Yokota C.
        • et al.
        Lipoprotein disorder in brain infarction and hemorrhage.
        Int J Clin Lab Res. 1998; 28: 39-46
        • Lindenstorm E.
        • Boysen C.
        • Nyboe J.
        Influence of total cholesterol, high density lipoprotein cholesterol, and triglyceride on risk of cerebrovascular disease: the Copenhagen City Hearts Study.
        Brit Med J. 1994; 309: 11-15
        • Giroud M.
        • Creisson E.
        • Fayolle H.
        • et al.
        Risk factors for primary cerebral hemorrhage: a population-based study—The Stroke Registry of Dijon.
        Neuroepidemiology. 1995; 14: 20-26
        • Hui-qiong L.
        • Lv-li L.
        • Xiao-chun L.
        • et al.
        Association of lipoprotein lipase HindⅢ gene polymorphisms with intracerebral hemorrhage.
        Guangxi Med J. 2006; 28: 1860-1862
        • Muñoz-Barrios S.
        • Guzmán- Guzmán I.P.
        • Muñoz-Valle J.F.
        • et al.
        Association of the HindⅢ and S447X polymorphism in LPL gene with hypertension and type2 diabetes in Mexican families.
        Dis Markers. 2012; 33: 313-320